Cellular Biomedicine Group Announces Closing of $10 Million Private Placement Offering

Cellular Biomedicine Group, Inc. , a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, today announced the closing of a private placement transaction under which it sold an aggregate of 1,492,537 shares of the Company's common stock, par value $0.001 per share , to selected private investors at ... (more)

http://ift.tt/1ifP4uE